Identity
- Trade Name
- Nano-Check Influenza+COVID-19 Dual Test FDA UDI
- Generic Name
- Multiple-genus respiratory virus antigen IVD, kit, rapid ICT, clinical FDA UDI
- Device Name
- The Nano-Check™ Influenza+COVID-19 Dual Test is a lateral flow immunochromatographic assay intended for in vitro rapid, simultaneous qualitative detection and differentiation of influenza A, and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly from anterior nasal swab specimens of individuals with signs and symptoms of respiratory infection consistent with COVID-19 within the first five (5) days of symptom onset when tested at least twice over three days with at least 48 hours between tests. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar. The Nano-Check™ Influenza+COVID-19 Dual Test is only for in vitro diagnostic use under the Food and Drug Administration’s Emergency Use Authorization. This product has not been cleared or approved. FDA UDI
- Model / Reference
- MD8151E FDA UDI
- Description
- The Nano-Check™ Influenza+COVID-19 Dual Test is a lateral flow immunochromatographic assay intended for in vitro rapid, simultaneous qualitative detection and differentiation of influenza A, and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly from anterior nasal swab specimens of individuals with signs and symptoms of respiratory infection consistent with COVID-19 within the first five (5) days of symptom onset when tested at least twice over three days with at least 48 hours between tests. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar. The Nano-Check™ Influenza+COVID-19 Dual Test is only for in vitro diagnostic use under the Food and Drug Administration’s Emergency Use Authorization. This product has not been cleared or approved. FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00895160002847 FDA UDI
- FDA Product Code
- QKP FDA UDIPSZ FDA UDI
- GMDN Term
- Multiple-genus respiratory virus antigen IVD, kit, rapid ICT, clinical FDA UDI
Classification
- Device Class
- N FDA UDI
- Regulation Number
- 866.3328 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
Yes
FDA UDI
Category: Multiple-genus respiratory virus antigen IVD, kit, rapid ICT, clinical
Nano-Check Influenza+COVID-19 Dual Test by Nano-Ditech Corporation — Class N — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Multiple-genus respiratory virus antigen IVD, kit, rapid ICT, clinical.
- WELLlife™ — WONDFO USA CO., LTD. · N
- BD Veritor™ Plus CLIA-Waived Combo Pack — BECTON DICKINSON AND COMPANY · Class I
- WELLlife™ — WONDFO USA CO., LTD. · Class II
- BD Veritor™ System Laboratory Combo Pack — BECTON DICKINSON AND COMPANY · Class I
- WELLlife™ — WONDFO USA CO., LTD. · Class II
- WELLlife™ — WONDFO USA CO., LTD. · Class II
- OSOM Flu SARS-CoV-2 Combo Test — Sekisui Diagnostics, LLC
- QuickFinder™ COVID-19/Flu Antigen ProTest — OSANG HEALTHCARE Co., Ltd. · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class N | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Nano-Ditech Corporation
Sources (1)
- FDA UDI f18c3d34-9ad5-4935-b28a-7afb37a80f9f 35 fields · synced Jun 9, 2026